194
Volume 5, Issue 10: Special Issue
(EJAR)
ISSN: 2181-2020
MPHAPP
THE 6TH INTERNATIONAL SCIENTIFIC AND PRACTICAL
CONFERENCE
“
MODERN PHARMACEUTICS: ACTUAL
PROBLEMS AND PROSPECTS
”
TASHKENT, OCTOBER 17, 2025
in-academy.uz
PHARMACOECONOMIC APPROACHES TO OPTIMIZING MEDICINE SUPPLY IN
THE REPUBLIC OF KAZAKHSTAN
Tursynbayeva Ayazhan Berdalykyzy
Nurtayeva Galiya Kadyrkhanovna
Kazakh national medical university named by S. D.Asfendiyarov, Almaty city, Republic of
Kazakhstan
https://doi.org/10.5281/zenodo.17332682
Relevance:
medicine supply for the population is a key element of the healthcare system of the
Republic of Kazakhstan. Under conditions of limited resources and rising drug prices, the importance
of rational use of budget funds increases. The application of pharmacoeconomic analysis methods
(cost-minimization, cost-effectiveness, cost-utility) makes it possible to compare costs and therapy
effectiveness, ensuring fair resource allocation and improved access to medicines.
Purpose of the study:
to study modern pharmacoeconomic methods and evaluate their
significance for optimizing medicine supply in the Republic of Kazakhstan.
Materials and methods:
a
review of the regulatory framework of the Republic of Kazakhstan
and the EAEU, as well as publications in Scopus, PubMed, and Web of Science databases from 2015
to 2025, was conducted. Data on the use of pharmacoeconomic methods in public procurement,
formulary systems, and clinical practice were analyzed.
Results:
the implementation of pharmacoeconomic approaches in the medicine supply system
of Kazakhstan allows reducing costs by 15–20% through the selection of the most evidence-based
drugs. The use of cost-effectiveness and cost-utility methods ensures comparability of costs and
clinical outcomes, which is important for the development of the National Drug Formulary and public
procurement. The application of pharmacoeconomic analysis in the development of clinical protocols
contributes to the integration of evidence-based medicine principles and increases system
transparency. The need to train specialists with competencies in pharmacoeconomics for practical
implementation of these methods has been highlighted.
Conclusions: pharmacoeconomics is an important tool for optimizing medicine supply in
Kazakhstan. A promising direction is the integration of economic evaluation into state healthcare
programs, training of specialists in pharmacoeconomic methods, and the development of local
research considering national specifics.
